Literature DB >> 27429161

Best Practices for the Diagnosis and Evaluation of Infants With Robin Sequence: A Clinical Consensus Report.

Corstiaan C Breugem1, Kelly N Evans2, Christian F Poets3, Sunjay Suri4, Arnaud Picard5, Charles Filip6, Emma C Paes1, Felicity V Mehendale7, Howard M Saal8, Hanneke Basart9, Jyotsna Murthy10, Koen F M Joosten11, Lucienne Speleman12, Marcus V M Collares13, Marie-José H van den Boogaard14, Marvick Muradin15, Maud Els-Marie Andersson16, Mikihiko Kogo17, Peter G Farlie18, Peter Don Griot19, Peter A Mossey20, Rona Slator21, Veronique Abadie22, Paul Hong23.   

Abstract

IMPORTANCE: Robin sequence (RS) is a congenital condition characterized by micrognathia, glossoptosis, and upper airway obstruction. Currently, no consensus exists regarding the diagnosis and evaluation of children with RS. An international, multidisciplinary consensus group was formed to begin to overcome this limitation.
OBJECTIVE: To report a consensus-derived set of best practices for the diagnosis and evaluation of infants with RS as a starting point for defining standards and management. EVIDENCE REVIEW: Based on a literature review and expert opinion, a clinical consensus report was generated.
FINDINGS: Because RS can occur as an isolated condition or as part of a syndrome or multiple-anomaly disorder, the diagnostic process for each newborn may differ. Micrognathia is hypothesized as the initiating event, but the diagnosis of micrognathia is subjective. Glossoptosis and upper airway compromise complete the primary characteristics of RS. It can be difficult to judge the severity of tongue base airway obstruction, and the possibility of multilevel obstruction exists. The initial assessment of the clinical features and severity of respiratory distress is important and has practical implications. Signs of upper airway obstruction can be intermittent and are more likely to be present when the infant is asleep. Therefore, sleep studies are recommended. Feeding problems are common and may be exacerbated by the presence of a cleft palate. The clinical features and their severity can vary widely and ultimately dictate the required investigations and treatments. CONCLUSIONS AND RELEVANCE: Agreed-on recommendations for the initial evaluation of RS and clinical descriptors are provided in this consensus report. Researchers and clinicians will ideally use uniform definitions and comparable assessments. Prospective studies and the standard application of validated assessments are needed to build an evidence base guiding standards of care for infants and children with RS.

Entities:  

Mesh:

Year:  2016        PMID: 27429161     DOI: 10.1001/jamapediatrics.2016.0796

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  22 in total

Review 1.  Sleep and respiratory outcomes in neonates with Pierre Robin sequence: a concise review.

Authors:  Christopher Kurian; Zarmina Ehsan
Journal:  Sleep Breath       Date:  2019-06-25       Impact factor: 2.816

2.  Cochlear Implantation in Pierre Robin Syndrome.

Authors:  Shubhangi Gupta; Mukesh Dagur; Mohnish Grover; Sunil Samdani; Rekha Singh; Rashmi Goyal; Gaurav Mehta; Raghav Mehta
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-21

3.  Accuracy and Reliability of 4D-CT and Flexible Laryngoscopy in Upper Airway Evaluation in Robin Sequence.

Authors:  Austin S Lam; Michael D Bindschadler; Kelly N Evans; Seth D Friedman; Matthew S Blessing; Randall Bly; Michael L Cunningham; Mark A Egbert; Russell E Ettinger; Emily R Gallagher; Richard A Hopper; Kaalan Johnson; Jonathan A Perkins; Erin K Romberg; Kathleen C Y Sie; Srinivas M Susarla; Carlton J Zdanski; Xing Wang; Jeffrey P Otjen; Francisco A Perez; John P Dahl
Journal:  Otolaryngol Head Neck Surg       Date:  2021-07-13       Impact factor: 3.497

4.  Objective measurements for upper airway obstruction in infants with Robin sequence: what are we measuring? A systematic review.

Authors:  Robrecht J H Logjes; Joanna E MacLean; Noor W de Cort; Christian F Poets; Véronique Abadie; Koen F M Joosten; Cory M Resnick; Ivy K Trindade-Suedam; Carlton J Zdanski; Christopher R Forrest; Frea H Kruisinga; Roberto L Flores; Kelly N Evans; Corstiaan C Breugem
Journal:  J Clin Sleep Med       Date:  2021-08-01       Impact factor: 4.324

5.  Mortality in Robin sequence: identification of risk factors.

Authors:  Robrecht J H Logjes; Maartje Haasnoot; Petra M A Lemmers; Mike F A Nicolaije; Marie-José H van den Boogaard; Aebele B Mink van der Molen; Corstiaan C Breugem
Journal:  Eur J Pediatr       Date:  2018-02-28       Impact factor: 3.183

6.  Multicenter study on the effectiveness of the pre-epiglottic baton plate for airway obstruction and feeding problems in Robin sequence.

Authors:  Christian F Poets; Christoph Maas; Wolfgang Buchenau; Joerg Arand; Anne Vierzig; Bert Braumann; Silvia Müller-Hagedorn
Journal:  Orphanet J Rare Dis       Date:  2017-03-09       Impact factor: 4.123

7.  Treatment of infants with Syndromic Robin sequence with modified palatal plates: a minimally invasive treatment option.

Authors:  Silvia Müller-Hagedorn; Wolfgang Buchenau; Jörg Arand; Margit Bacher; Christian F Poets
Journal:  Head Face Med       Date:  2017-03-30       Impact factor: 2.151

8.  Management of Airway Obstruction in Infants With Pierre Robin Sequence.

Authors:  Christopher M Runyan; Armando Uribe-Rivera; Shahryar Tork; Tasneem A Shikary; Zarmina Ehsan; K Nicole Weaver; Md Monir Hossain; Christopher B Gordon; Brian S Pan
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-05-10

9.  Early Communication Behaviors in Infants With Cleft Palate With and Without Robin Sequence: A Preliminary Study.

Authors:  Stephanie van Eeden; Yvonne Wren; Cristina McKean; Helen Stringer
Journal:  Cleft Palate Craniofac J       Date:  2021-07-14

10.  A Retrospective Longitudinal Treatment Review of Multidisciplinary Interventions in Nonsyndromic Robin Sequence With Cleft Palate.

Authors:  Pinelopi K Palaska; Gregory S Antonarakis; Sunjay Suri
Journal:  Cleft Palate Craniofac J       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.